{"database": "lobbying", "table": "lobbying_activities", "rows": [[1226819, "6d338806-0b06-4f68-89b1-7e1772df3c87", "Q1", "PURPLE ADVOCACY, LLC", 400870549, "DAVITA INC.", 2012, "first_quarter", "MMM", "End-stage renal disease reimbursement and policies related to Medicare Secondary Payor provisions in the new Healthcare Exchange.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2012-04-13T16:12:39.503000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1226819"], "units": {}, "query_ms": 0.5113209772389382, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}